Champions Oncology (CSBR) Property, Plant & Equipment (Net) Growth (3y) (2014 - 2026)
Powered by 
Analysis
Champions Oncology (CSBR) Property, Plant & Equipment (Net) Growth (3y) (2014 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PP&E (Net) Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Iqvia Holdings | 44.72 Bn | 42.64 Bn | 1.44 Bn | 2.36% |
| 2 | Medpace Holdings | 17.37 Bn | 16.87 Bn | 201.64 Mn | 11.02% |
| 3 | Icon | 13.65 Bn | 12.72 Bn | 479.29 Mn | 3.61% |
| 4 | Charles River Laboratories International | 13.13 Bn | 12.94 Bn | 452.07 Mn | -0.76% |
| 5 | Fortrea Holdings | 1.89 Bn | 1.72 Bn | 139.20 Mn | -9.72% |
| 6 | Evotec SE | 574.75 Mn | 148.87 Mn | - | -12.68% |
| 7 | Ginkgo Bioworks Holdings | 439.63 Mn | 355.09 Mn | 18.44 Mn | -18.86% |
| 8 | Champions Oncology | 69.43 Mn | 65.03 Mn | 7.70 Mn | -19.92% |
| 9 | MindWalk Holdings | 51.76 Mn | 46.29 Mn | 1.61 Mn | -57.05% |
| 10 | VivoSim Labs | 1.37 Mn | 1.37 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jul 31, 2026 | -19.92% |
| Apr 30, 2026 | -21.13% |
| Jan 31, 2026 | -22.15% |
| Oct 31, 2025 | -19.97% |
| Jul 31, 2025 | -18.09% |
| Apr 30, 2025 | -15.04% |
| Jan 31, 2025 | -10.33% |
| Oct 31, 2024 | -10.73% |
| Jul 31, 2024 | -7.97% |
| Apr 30, 2024 | -2.06% |
| Jan 31, 2024 | 5.65% |
| Oct 31, 2023 | 12.52% |
| Jul 31, 2023 | 18.47% |
| Apr 30, 2023 | 21.64% |
| Jan 31, 2023 | 34.24% |
| Oct 31, 2022 | 35.75% |
| Jul 31, 2022 | 35.23% |
| Apr 30, 2022 | 40.98% |
| Jan 31, 2022 | 39.45% |
| Oct 31, 2021 | 40.18% |